The results showed that the expression level of ZFAS1 was positively associated with clinical T stage (P = .0281) and TNM stage (P = .0281) in NPC patients, while associations with gender (P = .7846), age (P = .3520), histological classification (P = .7570) or relapse (P = .1757) were not significant. The gene discussed is ZFAS1; the disease is nasopharyngeal carcinoma.